Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL OCCUPATIONAL THERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL OCCUPATIONAL THERAPY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL OCCUPATIONAL THERAPY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 PATENT ANALYSIS
6.1.1 PATENT LANDSCAPE
6.1.2 USPTO NUMBER
6.1.3 PATENT EXPIRY
6.1.4 EPIO NUMBER
6.1.5 PATENT STRENGTH AND QUALITY
6.1.6 PATENT CLAIMS
6.1.7 PATENT CITATIONS
6.1.8 PATENT LITIGATION AND LICENSING
6.1.9 FILE OF PATENT
6.1.10 PATENT RECEIVED CONTRIES
6.1.11 TECHNOLOGY BACKGROUND
6.2 DRUG TREATMENT RATE BY MATURED MARKETS
6.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
6.4 PATIENT FLOW DIAGRAM
6.5 KEY PRICING STRATEGIES
6.6 KEY PATIENT ENROLLMENT STRATEGIES
6.7 INTERVIEWS WITH SPECIALIST
6.8 OTHER KOL SNAPSHOTS
7 EPIDEMIOLOGY
7.1 INCIDENCE OF ALL BY GENDER
7.2 TREATMENT RATE
7.3 MORTALITY RATE
7.4 DRUG ADHERENCE AND THERAPY SWITCH MODEL
7.5 PATIENT TREATMENT SUCCESS RATES
8 MERGERS AND ACQUISITION
8.1 LICENSING
8.2 COMMERCIALIZATION AGREEMENTS
9 REGULATORY FRAMEWORK
9.1 REGULATORY APPROVAL PROCESS
9.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
9.3 REGULATORY APPROVAL PATHWAYS
9.4 LICENSING AND REGISTRATION
9.5 POST-MARKETING SURVEILLANCE
9.6 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES
10 PIPELINE ANALYSIS
10.1 CLINICAL TRIALS AND PHASE ANALYSIS
10.2 DRUG THERAPY PIPELINE
10.3 PHASE III CANDIDATES
10.4 PHASE II CANDIDATES
10.5 PHASE I CANDIDATES
10.6 OTHERS (PRE-CLINICAL AND RESEARCH)
TABLE 1 GLOBAL CLINICAL TRIAL MARKET FOR XX
Company Name Therapeutic Area
XX XX
XX XX
XX XX
XX XX
XX XX
XX XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 2 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE
Phase Number of Projects
Preclinical/Research Projects XX
Clinical Development XX
Phase I XX
Phase II XX
Phase III XX
U.S. Filed/Approved But Not Yet Marketed XX
Total XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 3 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE
Therapeutic Area Preclinical/ Research Project
XX XX
XX XX
XX XX
XX XX
XX XX
Total Projects XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 4 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE
Technology Preclinical/ Research Project
XX XX
XX XX
XX XX
XX XX
XX XX
Total Projects XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
FIGURE 1 TOP ENTITIES BASED ON R&D GLANCE FOR XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
11 MARKETED DRUG ANALYSIS
11.1 DRUG
11.1.1 BRAND NAME
11.1.2 GENERICS NAME
11.2 THERAPEUTIC INDICTION
11.3 PHARMACOLOGICAL CLASS OF THE DRUG
11.4 DRUG PRIMARY INDICATION
11.5 MARKET STATUS
11.6 MEDICATION TYPE
11.7 DRUG DOSAGES FORM
11.8 DOSAGES AVAILABILITY
11.9 DRUG ROUTE OF ADMINISTRATION
11.1 DOSING FREQUENCY
11.11 DRUG INSIGHT
11.12 AN OVERVIEW OF THE DRUG DEVELOPMENT ACTIVITIES SUCH AS REGULATORY MILSTONE, SAFETY DATA AND EFFICACY DATA, MARKET EXCLUSIVITY DATA.
11.12.1 FORECAST MARKET OUTLOOK
11.12.2 CROSS COMPETITION
11.12.3 THERAPEUTIC PORTFOLIO
11.12.4 CURRENT DEVELOPMENT SCENARIO
12 MARKET ACCESS
12.1 10-YEAR MARKET FORECAST
12.2 CLINICAL TRIAL RECENT UPDATES
12.3 ANNUAL NEW FDA APPROVED DRUGS
12.4 DRUGS MANUFACTURER AND DEALS
12.5 MAJOR DRUG UPTAKE
12.6 CURRENT TREATMENT PRACTICES
12.7 IMPACT OF UPCOMING THERAPY
13 R & D ANALYSIS
13.1 COMPARATIVE ANALYSIS
13.2 DRUG DEVELOPMENTAL LANDSCAPE
13.3 IN-DEPTH INSIGHTS ON REGULATORY MILESTONES
13.4 THERAPEUTIC ASSESSMENT
13.5 ASSET-BASED COLLABORATIONS AND PARTNERSHIPS
14 MARKET OVERVIEW
14.1 DRIVERS
14.2 RESTRAINTS
14.3 OPPORTUNITIES
14.4 CHALLENGES
15 GLOBAL OCCUPATIONAL THERAPY MARKET, BY TYPE
15.1 OVERVIEW
15.2 MANUAL THERAPIES
15.3 DIGITAL SOLUTIONS
16 GLOBAL OCCUPATIONAL THERAPY MARKET, BY PRODUCT
16.1 OVERVIEW
16.2 CLOUD-BASED
16.3 ON-PREMISES
17 GLOBAL OCCUPATIONAL THERAPY MARKET, BY SERVICES
17.1 OVERVIEW
17.2 ACQUIRED BRAIN INJURY
17.2.1 FINE MOTOR SKILLS
17.2.2 HAND –EYE COORDINATION
17.2.3 BASIC SELF CARE
17.2.4 BEHAVIOURAL COACHING
17.2.5 SPECIALZIED EQUIPMENT
17.2.5.1. WHEELCHAIRS
17.2.5.2. SPLINTS
17.2.5.3. BATHING QUIPMENT
17.2.5.4. DRESSING DEVICE
17.2.5.5. COMMUNICATION AID
17.2.5.6. OTHERS
17.3 PSYCHOLOGICAL DISABILITIES
17.3.1 FINE MOTOR SKILLS
17.3.2 HAND –EYE COORDINATION
17.3.3 BASIC SELF CARE
17.3.4 BEHAVIOURAL COACHING
17.3.5 SPECIALZIED EQUIPMENT
17.3.5.1. WHEELCHAIRS
17.3.5.2. SPLINTS
17.3.5.3. BATHING QUIPMENT
17.3.5.4. DRESSING DEVICE
17.3.5.5. COMMUNICATION AID
17.3.5.6. OTHERS
17.4 DEVELOPMENTAL DISABILITIES
17.4.1 FINE MOTOR SKILLS
17.4.2 HAND –EYE COORDINATION
17.4.3 BASIC SELF CARE
17.4.4 BEHAVIOURAL COACHING
17.4.5 SPECIALZIED EQUIPMENT
17.4.5.1. WHEELCHAIRS
17.4.5.2. SPLINTS
17.4.5.3. BATHING QUIPMENT
17.4.5.4. DRESSING DEVICE
17.4.5.5. COMMUNICATION AID
17.4.5.6. OTHERS
17.5 CHRONIC PAIN
17.5.1 FINE MOTOR SKILLS
17.5.2 HAND –EYE COORDINATION
17.5.3 BASIC SELF CARE
17.5.4 BEHAVIOURAL COACHING
17.5.5 SPECIALZIED EQUIPMENT
17.5.5.1. WHEELCHAIRS
17.5.5.2. SPLINTS
17.5.5.3. BATHING QUIPMENT
17.5.5.4. DRESSING DEVICE
17.5.5.5. COMMUNICATION AID
17.5.5.6. OTHERS
17.6 ORTHOPEDIC INJURY
17.6.1 FINE MOTOR SKILLS
17.6.2 HAND –EYE COORDINATION
17.6.3 BASIC SELF CARE
17.6.4 BEHAVIOURAL COACHING
17.6.5 SPECIALZIED EQUIPMENT
17.6.5.1. WHEELCHAIRS
17.6.5.2. SPLINTS
17.6.5.3. BATHING QUIPMENT
17.6.5.4. DRESSING DEVICE
17.6.5.5. COMMUNICATION AID
17.6.5.6. OTHERS
17.7 AUTISM
17.7.1 FINE MOTOR SKILLS
17.7.2 HAND –EYE COORDINATION
17.7.3 BASIC SELF CARE
17.7.4 BEHAVIOURAL COACHING
17.7.5 SPECIALZIED EQUIPMENT
17.7.5.1. WHEELCHAIRS
17.7.5.2. SPLINTS
17.7.5.3. BATHING QUIPMENT
17.7.5.4. DRESSING DEVICE
17.7.5.5. COMMUNICATION AID
17.7.5.6. OTHERS
17.8 VOCATIONAL INTERVENTIONS
17.8.1 FINE MOTOR SKILLS
17.8.2 HAND –EYE COORDINATION
17.8.3 BASIC SELF CARE
17.8.4 BEHAVIOURAL COACHING
17.8.5 SPECIALZIED EQUIPMENT
17.8.5.1. WHEELCHAIRS
17.8.5.2. SPLINTS
17.8.5.3. BATHING QUIPMENT
17.8.5.4. DRESSING DEVICE
17.8.5.5. COMMUNICATION AID
17.8.5.6. OTHERS
17.9 BEHAVIORAL IMPAIRMENTS
17.9.1 FINE MOTOR SKILLS
17.9.2 HAND –EYE COORDINATION
17.9.3 BASIC SELF CARE
17.9.4 BEHAVIOURAL COACHING
17.9.5 SPECIALZIED EQUIPMENT
17.9.5.1. WHEELCHAIRS
17.9.5.2. SPLINTS
17.9.5.3. BATHING QUIPMENT
17.9.5.4. DRESSING DEVICE
17.9.5.5. COMMUNICATION AID
17.9.5.6. OTHERS
17.1 COGNITIVE REHABILITATION
17.10.1 FINE MOTOR SKILLS
17.10.2 HAND –EYE COORDINATION
17.10.3 BASIC SELF CARE
17.10.4 BEHAVIOURAL COACHING
17.10.5 SPECIALZIED EQUIPMENT
17.10.5.1. WHEELCHAIRS
17.10.5.2. SPLINTS
17.10.5.3. BATHING QUIPMENT
17.10.5.4. DRESSING DEVICE
17.10.5.5. COMMUNICATION AID
17.10.5.6. OTHERS
17.11 CONCUSSON
17.11.1 FINE MOTOR SKILLS
17.11.2 HAND –EYE COORDINATION
17.11.3 BASIC SELF CARE
17.11.4 BEHAVIOURAL COACHING
17.11.5 SPECIALZIED EQUIPMENT
17.11.5.1. WHEELCHAIRS
17.11.5.2. SPLINTS
17.11.5.3. BATHING QUIPMENT
17.11.5.4. DRESSING DEVICE
17.11.5.5. COMMUNICATION AID
17.11.5.6. OTHERS
17.12 ADHD
17.13 OTHERS
18 GLOBAL OCCUPATIONAL THERAPY MARKET, BY AGE GROUP
18.1 OVERVIEW
18.2 PEDIATRIC
18.3 ADULT
18.4 GERIATRIC
19 GLOBAL OCCUPATIONAL THERAPY MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS
19.2.1 PUBLIC
19.2.2 PRIVATE
19.3 SPECIALTY CLINICS
19.4 HOME HEALTHCARE
19.5 OTHERS
20 GLOBAL OCCUPATIONAL THERAPY MARKET, BY COUNTRY
GLOBAL OCCUPATIONAL THERAPY MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
20.1 NORTH AMERICA
20.1.1 U.S.
20.1.2 CANADA
20.1.3 MEXICO
20.2 EUROPE
20.2.1 GERMANY
20.2.2 FRANCE
20.2.3 U.K.
20.2.4 ITALY
20.2.5 SPAIN
20.2.6 RUSSIA
20.2.7 TURKEY
20.2.8 NETHERLANDS
20.2.9 SWITZERLAND
20.2.10 REST OF EUROPE
20.3 ASIA-PACIFIC
20.3.1 JAPAN
20.3.2 CHINA
20.3.3 SOUTH KOREA
20.3.4 INDIA
20.3.5 AUSTRALIA
20.3.6 SINGAPORE
20.3.7 THAILAND
20.3.8 MALAYSIA
20.3.9 INDONESIA
20.3.10 PHILIPPINES
20.3.11 REST OF ASIA-PACIFIC
20.4 SOUTH AMERICA
20.4.1 BRAZIL
20.4.2 ARGENTINA
20.4.3 REST OF SOUTH AMERICA
20.5 MIDDLE EAST AND AFRICA
20.5.1 SOUTH AFRICA
20.5.2 SAUDI ARABIA
20.5.3 UAE
20.5.4 EGYPT
20.5.5 ISRAEL
20.5.6 REST OF MIDDLE EAST AND AFRICA
20.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
21 GLOBAL OCCUPATIONAL THERAPY MARKET, COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GLOBAL
21.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
21.3 COMPANY SHARE ANALYSIS: EUROPE
21.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
21.5 MERGERS & ACQUISITIONS
21.6 NEW PRODUCT DEVELOPMENT & APPROVALS
21.7 EXPANSIONS
21.8 REGULATORY CHANGES
21.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
22 GLOBAL OCCUPATIONAL THERAPY MARKET, SWOT AND DBR ANALYSIS
23 GLOBAL OCCUPATIONAL THERAPY MARKET, COMPANY PROFILE
23.1 WEBPT
23.1.1 COMPANY OVERVIEW
23.1.2 REVENUE ANALYSIS
23.1.3 GEOGRAPHIC PRESENCE
23.1.4 PRODUCT PORTFOLIO
23.1.5 RECENT DEVELOPMENTS
23.2 PREMISE HEALTH
23.2.1 COMPANY OVERVIEW
23.2.2 REVENUE ANALYSIS
23.2.3 GEOGRAPHIC PRESENCE
23.2.4 PRODUCT PORTFOLIO
23.2.5 RECENT DEVELOPMENTS
23.3 NET HEALTH
23.3.1 COMPANY OVERVIEW
23.3.2 REVENUE ANALYSIS
23.3.3 GEOGRAPHIC PRESENCE
23.3.4 PRODUCT PORTFOLIO
23.3.5 RECENT DEVELOPMENTS
23.4 OT SERVICES GROUP
23.4.1 COMPANY OVERVIEW
23.4.2 REVENUE ANALYSIS
23.4.3 GEOGRAPHIC PRESENCE
23.4.4 PRODUCT PORTFOLIO
23.4.5 RECENT DEVELOPMENTS
23.5 OASIS OCCUPATIONAL THERAPY SERVICES
23.5.1 COMPANY OVERVIEW
23.5.2 REVENUE ANALYSIS
23.5.3 GEOGRAPHIC PRESENCE
23.5.4 PRODUCT PORTFOLIO
23.5.5 RECENT DEVELOPMENTS
23.6 ALLIANCE PHYSICAL THERAPY PARTNERS
23.6.1 COMPANY OVERVIEW
23.6.2 REVENUE ANALYSIS
23.6.3 GEOGRAPHIC PRESENCE
23.6.4 PRODUCT PORTFOLIO
23.6.5 RECENT DEVELOPMENTS
23.7 BLUESTONE THERAPY
23.7.1 COMPANY OVERVIEW
23.7.2 REVENUE ANALYSIS
23.7.3 GEOGRAPHIC PRESENCE
23.7.4 PRODUCT PORTFOLIO
23.7.5 RECENT DEVELOPMENTS
23.8 INNOVATIVE OCCUPATIONAL THERAPY SERVICES
23.8.1 COMPANY OVERVIEW
23.8.2 REVENUE ANALYSIS
23.8.3 GEOGRAPHIC PRESENCE
23.8.4 PRODUCT PORTFOLIO
23.8.5 RECENT DEVELOPMENTS
23.9 PROFESSIONAL THERAPY SERVICES
23.9.1 COMPANY OVERVIEW
23.9.2 REVENUE ANALYSIS
23.9.3 GEOGRAPHIC PRESENCE
23.9.4 PRODUCT PORTFOLIO
23.9.5 RECENT DEVELOPMENTS
EAGLE CREEK THERAPY SERVICES
23.9.6 COMPANY OVERVIEW
23.9.7 REVENUE ANALYSIS
23.9.8 GEOGRAPHIC PRESENCE
23.9.9 PRODUCT PORTFOLIO
23.9.10 RECENT DEVELOPMENTS
23.1 ENCOMPASS HEALTH
23.10.1 COMPANY OVERVIEW
23.10.2 REVENUE ANALYSIS
23.10.3 GEOGRAPHIC PRESENCE
23.10.4 PRODUCT PORTFOLIO
23.10.5 RECENT DEVELOPMENTS
23.11 CALIFORNIA THERAPY SERVICES
23.11.1 COMPANY OVERVIEW
23.11.2 REVENUE ANALYSIS
23.11.3 GEOGRAPHIC PRESENCE
23.11.4 PRODUCT PORTFOLIO
23.11.5 RECENT DEVELOPMENTS
23.12 OPTIMA HEALTH CARE, INC
23.12.1 COMPANY OVERVIEW
23.12.2 REVENUE ANALYSIS
23.12.3 GEOGRAPHIC PRESENCE
23.12.4 PRODUCT PORTFOLIO
23.12.5 RECENT DEVELOPMENTS
23.13 CLINICSOURCE
23.13.1 COMPANY OVERVIEW
23.13.2 REVENUE ANALYSIS
23.13.3 GEOGRAPHIC PRESENCE
23.13.4 PRODUCT PORTFOLIO
23.13.5 RECENT DEVELOPMENTS
23.14 BIO-MED INTERNATIONAL PVT LTD.
23.14.1 COMPANY OVERVIEW
23.14.2 REVENUE ANALYSIS
23.14.3 GEOGRAPHIC PRESENCE
23.14.4 PRODUCT PORTFOLIO
23.14.5 RECENT DEVELOPMENTS
23.15 DIVINE PHYSIOTHERAPY EQUIPMENTS
23.15.1 COMPANY OVERVIEW
23.15.2 REVENUE ANALYSIS
23.15.3 GEOGRAPHIC PRESENCE
23.15.4 PRODUCT PORTFOLIO
23.15.5 RECENT DEVELOPMENTS
23.16 POWERBACK REHABILITATION
23.16.1 COMPANY OVERVIEW
23.16.2 REVENUE ANALYSIS
23.16.3 GEOGRAPHIC PRESENCE
23.16.4 PRODUCT PORTFOLIO
23.16.5 RECENT DEVELOPMENTS
23.17 AEGIS THERAPEUTICS
23.17.1 COMPANY OVERVIEW
23.17.2 REVENUE ANALYSIS
23.17.3 GEOGRAPHIC PRESENCE
23.17.4 PRODUCT PORTFOLIO
23.17.5 RECENT DEVELOPMENTS
23.18 SAGE CARE THERAPY SERVICES
23.18.1 COMPANY OVERVIEW
23.18.2 REVENUE ANALYSIS
23.18.3 GEOGRAPHIC PRESENCE
23.18.4 PRODUCT PORTFOLIO
23.18.5 RECENT DEVELOPMENTS
23.19 FELICITY INC
23.19.1 COMPANY OVERVIEW
23.19.2 REVENUE ANALYSIS
23.19.3 GEOGRAPHIC PRESENCE
23.19.4 PRODUCT PORTFOLIO
23.19.5 RECENT DEVELOPMENTS
23.2 RKS OCCUPATIONAL THERAPY SERVICES
23.20.1 COMPANY OVERVIEW
23.20.2 REVENUE ANALYSIS
23.20.3 GEOGRAPHIC PRESENCE
23.20.4 PRODUCT PORTFOLIO
23.20.5 RECENT DEVELOPMENTS
23.21 ALLCARE THERAPY SERVICES
23.21.1 COMPANY OVERVIEW
23.21.2 REVENUE ANALYSIS
23.21.3 GEOGRAPHIC PRESENCE
23.21.4 PRODUCT PORTFOLIO
23.21.5 RECENT DEVELOPMENTS
23.22 DYNAMIC THERAPY FOR KIDS
23.22.1 COMPANY OVERVIEW
23.22.2 REVENUE ANALYSIS
23.22.3 GEOGRAPHIC PRESENCE
23.22.4 PRODUCT PORTFOLIO
23.22.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
24 CONCLUSION
25 QUESTIONNAIRE
26 ABOUT DATA BRIDGE MARKET RESEARCH
